{"id":"https://openalex.org/W79110731","doi":"https://doi.org/10.1007/bf03402101","title":"Schizophrenia: Neural Mechanisms for Novel Therapies","display_name":"Schizophrenia: Neural Mechanisms for Novel Therapies","alternate_titles":[],"publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W79110731","doi":"https://doi.org/10.1007/bf03402101","mag":"79110731","pmid":"https://pubmed.ncbi.nlm.nih.gov/12765334","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1430383"},"language":"en","primary_location":{"id":"doi:10.1007/bf03402101","doi":"https://doi.org/10.1007/bf03402101","is_oa":true,"landing_page_url":"https://doi.org/10.1007/bf03402101","pdf_url":"https://molmed.biomedcentral.com/track/pdf/10.1007/BF03402101","source":{"id":"https://openalex.org/S6769275","display_name":"Molecular Medicine","issn_l":"1076-1551","issn":["1076-1551","1528-3658"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W79110731"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://molmed.biomedcentral.com/track/pdf/10.1007/BF03402101","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069018183","display_name":"Akira Sawa","orcid":"https://orcid.org/0000-0003-1401-3008","observed_orcids":["https://orcid.org/0000-0003-1401-3008"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Akira Sawa","raw_affiliation_strings":["Department of Neuroscience, Johns Hopkins University, School of Medicine, 725 N. Wolfe Street, Baltimore, MD, 21205, USA","Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD, 21205, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, Johns Hopkins University, School of Medicine, 725 N. Wolfe Street, Baltimore, MD, 21205, USA","institution_ids":["https://openalex.org/I145311948"]},{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD, 21205, USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020208893","display_name":"Solomon H. Snyder","orcid":"https://orcid.org/0000-0002-6818-7022","observed_orcids":["https://orcid.org/0000-0002-6818-7022"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Solomon H. Snyder","raw_affiliation_strings":["Department of Neuroscience, Johns Hopkins University, School of Medicine, 725 N. Wolfe Street, Baltimore, MD, 21205, USA","Department of Pharmacology and Molecular Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD, 21205, USA","Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD, 21205, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, Johns Hopkins University, School of Medicine, 725 N. Wolfe Street, Baltimore, MD, 21205, USA","institution_ids":["https://openalex.org/I145311948"]},{"raw_affiliation_string":"Department of Pharmacology and Molecular Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD, 21205, USA","institution_ids":["https://openalex.org/I145311948"]},{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD, 21205, USA","institution_ids":["https://openalex.org/I145311948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5020208893"],"corresponding_institution_ids":["https://openalex.org/I145311948"],"apc_list":{"value":3190,"currency":"USD","value_usd":3190},"apc_paid":{"value":3190,"currency":"USD","value_usd":3190},"fwci":2.3133,"has_fulltext":true,"cited_by_count":61,"citation_normalized_percentile":{"value":0.86924567,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"9","issue":"1-2","first_page":"3","last_page":"9"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":1.0},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.7250000238418579},{"id":"https://openalex.org/keywords/dopamine-receptor-antagonism","display_name":"dopamine receptor antagonism","score":0.6990000009536743},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.8569999933242798},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.9470000267028809},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8949999809265137},{"id":"https://openalex.org/keywords/glutamatergic-neurotransmission","display_name":"glutamatergic neurotransmission","score":0.9369999766349792},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.9800000190734863},{"id":"https://openalex.org/keywords/d-serine","display_name":"D-serine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/alpha7-nicotinic-acetylcholine-receptor","display_name":"alpha7 nicotinic acetylcholine receptor","score":0.9869999885559082},{"id":"https://openalex.org/keywords/gene-discovery","display_name":"gene discovery","score":0.5090000033378601},{"id":"https://openalex.org/keywords/disc1","display_name":"DISC1","score":0.9549999833106995},{"id":"https://openalex.org/keywords/dysbindin","display_name":"dysbindin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/neuregulin","display_name":"neuregulin","score":0.949999988079071},{"id":"https://openalex.org/keywords/novel-therapies","display_name":"new drugs","score":0.6290000081062317}],"concepts":[{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7008522152900696},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.6992185115814209},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5093982815742493},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5044442415237427},{"id":"https://openalex.org/C188987157","wikidata":"https://www.wikidata.org/wiki/Q7030581","display_name":"Nicotinic agonist","level":3,"score":0.47810620069503784},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46226370334625244},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.45775923132896423},{"id":"https://openalex.org/C200170125","wikidata":"https://www.wikidata.org/wiki/Q969316","display_name":"Neurotransmission","level":3,"score":0.4293006360530853},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.40078210830688477},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.2934272289276123},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.219955712556839},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1026776134967804}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009434","descriptor_name":"Neural Pathways","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009434","descriptor_name":"Neural Pathways","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017981","descriptor_name":"Receptors, Neurotransmitter","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D017981","descriptor_name":"Receptors, Neurotransmitter","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/bf03402101","doi":"https://doi.org/10.1007/bf03402101","is_oa":true,"landing_page_url":"https://doi.org/10.1007/bf03402101","pdf_url":"https://molmed.biomedcentral.com/track/pdf/10.1007/BF03402101","source":{"id":"https://openalex.org/S6769275","display_name":"Molecular Medicine","issn_l":"1076-1551","issn":["1076-1551","1528-3658"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1430383","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1430383/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Med","raw_type":"Text"},{"id":"pmid:12765334","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12765334","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular medicine (Cambridge, Mass.)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/bf03402101","doi":"https://doi.org/10.1007/bf03402101","is_oa":true,"landing_page_url":"https://doi.org/10.1007/bf03402101","pdf_url":"https://molmed.biomedcentral.com/track/pdf/10.1007/BF03402101","source":{"id":"https://openalex.org/S6769275","display_name":"Molecular Medicine","issn_l":"1076-1551","issn":["1076-1551","1528-3658"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1609066045","display_name":"Drug Abuse Research Center","funder_award_id":"P50DA000266","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G1615557336","display_name":null,"funder_award_id":"DA 00074","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G3123260968","display_name":"Neurochemical Actions of Psychotropic Drugs","funder_award_id":"R01MH018501","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G5437238147","display_name":null,"funder_award_id":"MH\u201018501","funder_id":"https://openalex.org/F4320332505","funder_display_name":"U.S. Public Health Service"},{"id":"https://openalex.org/G58031844","display_name":null,"funder_award_id":"DA.00266","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G7243145451","display_name":null,"funder_award_id":"DA-00074","funder_id":"https://openalex.org/F4320332505","funder_display_name":"U.S. Public Health Service"},{"id":"https://openalex.org/G7679270143","display_name":"Neurotransmitter Receptors","funder_award_id":"K05DA000074","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G8874643029","display_name":"Neurochemical Actions of Psychotropic Drugs","funder_award_id":"R37MH018501","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G913113481","display_name":null,"funder_award_id":"MH-18501","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320309530","display_name":"Stanley Medical Research Institute","ror":"https://ror.org/01pj5nn22"},{"id":"https://openalex.org/F4320311440","display_name":"National Alliance for Research on Schizophrenia and Depression","ror":"https://ror.org/03a63f080"},{"id":"https://openalex.org/F4320332505","display_name":"U.S. Public Health Service","ror":"https://ror.org/05xf94514"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W79110731.pdf","grobid_xml":"https://content.openalex.org/works/W79110731.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W1544982068","https://openalex.org/W1562031166","https://openalex.org/W1566810616","https://openalex.org/W1589759057","https://openalex.org/W1967979754","https://openalex.org/W1987938829","https://openalex.org/W1991503782","https://openalex.org/W1991820785","https://openalex.org/W1999115255","https://openalex.org/W2001942712","https://openalex.org/W2009447429","https://openalex.org/W2019363012","https://openalex.org/W2020237866","https://openalex.org/W2025759097","https://openalex.org/W2028884770","https://openalex.org/W2032208151","https://openalex.org/W2032866243","https://openalex.org/W2036538226","https://openalex.org/W2042325100","https://openalex.org/W2051582011","https://openalex.org/W2061506085","https://openalex.org/W2063505213","https://openalex.org/W2068953489","https://openalex.org/W2069102021","https://openalex.org/W2082656717","https://openalex.org/W2089021168","https://openalex.org/W2092416470","https://openalex.org/W2095409179","https://openalex.org/W2100120613","https://openalex.org/W2105837661","https://openalex.org/W2108250183","https://openalex.org/W2110334080","https://openalex.org/W2124888321","https://openalex.org/W2133957865","https://openalex.org/W2135772494","https://openalex.org/W2136962131","https://openalex.org/W2147666048","https://openalex.org/W2154263373","https://openalex.org/W2156026059","https://openalex.org/W2156026700","https://openalex.org/W2156035025","https://openalex.org/W2156305088","https://openalex.org/W2158137297","https://openalex.org/W2158370744","https://openalex.org/W2169817544","https://openalex.org/W2171686853","https://openalex.org/W2284323937","https://openalex.org/W4239917637","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2032249286","https://openalex.org/W1987249329","https://openalex.org/W1983457306","https://openalex.org/W2035249251","https://openalex.org/W2116043221","https://openalex.org/W2133569390","https://openalex.org/W2960385316","https://openalex.org/W2092271259","https://openalex.org/W157021211","https://openalex.org/W2427519459"],"abstract_inverted_index":{"Although":[0],"valuable":[1],"antischizophrenic":[2],"drugs":[3,17],"exist,":[4],"they":[5],"only":[6],"partially":[7],"ameliorate":[8],"symptoms":[9,27],"and":[10,39,64,110],"elicit":[11],"substantial":[12],"side":[13],"effects.":[14],"Classic":[15],"neuroleptic":[16],"act":[18],"by":[19],"blocking":[20],"dopamine":[21],"receptors.":[22],"They":[23],"can":[24],"relieve":[25],"some":[26],"but":[28],"not":[29],"behavioral":[30],"withdrawal":[31],"features":[32],"that":[33,97],"are":[34,71],"designated":[35],"\"negative\"":[36],"symptoms.":[37,51],"Clozapine":[38],"related":[40],"newer":[41],"atypical":[42],"neuroleptics":[43],"may":[44,55,82,98],"be":[45,84],"more":[46],"efficacious":[47],"in":[48],"relieving":[49],"negative":[50],"Understandng":[52],"their":[53],"actions":[54],"facilitate":[56],"new":[57],"drug":[58],"discovery.":[59],"Agents":[60],"influencing":[61],"glutamate":[62],"neurotransmission":[63],"N-methyl-D-aspartate":[65],"receptors,":[66],"especially":[67],"the":[68,75],"cotransmitter":[69],"D-serine,":[70],"promising.":[72],"Stimulation":[73],"of":[74,78,101],"alpha7":[76],"subtype":[77],"nicotinic":[79],"acetylcholine":[80],"receptor":[81],"also":[83],"efficacious.":[85],"The":[86],"search":[87],"for":[88],"genes":[89,106],"linked":[90],"to":[91],"schizophrenia":[92],"has":[93],"revealed":[94],"several":[95],"leads":[96],"permit":[99],"development":[100],"novel":[102],"therapeutic":[103],"agents.":[104],"Promising":[105],"include":[107],"disrupted-in-schizophrenia-1,":[108],"dysbindin,":[109],"neuregulin.":[111]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W79110731","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
